Showing results (311-320 of 321) with videos related to
Sort By:
Pageof 33
Journal of the American Geriatrics Society|September 1, 1997
The process of care in preventive in-home comprehensive geriatric assessmentC A Alessi, A E Stuck, H U Aronow, et al.The Journal of Urology|May 1, 1997
Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in childrenJ S Elder, C A Peters, B S Arant, et al.Nature|April 9, 2013
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAXMyunggon Ko, Jungeun An, Hozefa S Bandukwala, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 23, 2017
FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-upR R Nathavitharana, P Daru, A E Barrera, et al.Annals of the New York Academy of Sciences|December 13, 1996
Trials of 9-amino-20(S)-camptothecin in BostonJ P Eder, E Rubin, R Stone, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials GroupH A Kessler, S Hurwitz, C Farthing, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2014
Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effectsJi Young Yoo, Brian S Hurwitz, Chelsea Bolyard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell ImmunotherapyJi Young Yoo, Alena Cristina Jaime-Ramirez, Chelsea Bolyard, et al.The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.The Lancet. Oncology|May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trialYelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.Pageof 33